The Court entered an Order resetting the July 26, 2023 status conference for September 12, 2023, at 9:00 a.m.

The Court held a status conference.

The Court entered Pretrial Order No. 4, setting forth the operable Plaintiff Fact Sheet, authorizations, and Defendant Fact Sheet.

The Court held a status conference.

The Court entered an Order appointing John F. Olinde as Liaison Counsel for the 505(b)(2) Defendants. 

The Court entered Pretrial Order No. 3 requesting applications and nominations for the appointment of liaison counsel for the 505(b)(2) Defendants.

The Court held Science Day. 

The Court set a status conference for March 31, 2023 at 9:00 a.m.

The Court reset Science Day for February 13, 2023 at 9:00 a.m.

The Court ruled on Defendant Sanofi’s Motion to Dismiss for Failure to State a Claim.

The Court ruled on the 505(b)(2) Defendants’ Motion to Dismiss for Failure to State a Claim.

The Court issued an order providing the protocol for Science Day.

The Court issued an order setting Science Day for December 19, 2022 at 9:00 a.m.

The Court held oral argument on Defendants’ Motions to Dismiss for Failure to State a Claim. 

The Court issued an order denying Defendant McKesson’s Motion to Dismiss as moot. 

The Court issued an order continuing Science Day. 

The Court issued an order setting oral argument for October 5, 2022 at 10:30 a.m.

The Court entered this stipulated order establishing the protocol for streamlined service on Sun Pharmaceuticals, Inc. 

The Court issued an order setting oral argument for October 5, 2022.

The Court entered this stipulated order establishing the protocol for streamlined service on Sandoz, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Hospira Inc., Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc., and Pfizer Inc.  

The Court issued this order regarding filing requests for summons and summons returns and waivers.

The Court attached the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Case Management Order No. 2.  

The Court entered this stipulated order establishing the protocol for streamlined service on Sagent Pharmaceuticals, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Actavis LLC f/k/a Actavis Inc. and Actavis Pharma, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Accord Healthcare, Inc.

The Court entered this stipulated order establishing the protocol for streamlined service on sanofi-aventis U.S. LLC. 

The Court set certain deadlines for master and short form complaints, motions to dismiss, and master answers. 

The Court held a general status conference and discussed the items set forth in Joint Report No. 24.

The Court held a conference with lead and liaison counsel and discussed the topics on the attached joint agenda. 

The Court issued a direct filing order. 

The Court appointed liaison counsel and the plaintiffs’ steering committee. 

The Court held the initial pretrial conference and discussed the topics on the attached joint agenda. 

The Court issued a pretrial order establishing rules and procedures to govern this litigation. The initial pretrial conference will be held on March 31, 2022, at 9:30 a.m. in Judge Jane Triche Milazzo’s courtroom. The Court set the following deadlines:
•    Applications/nominations for the designation of Liaison Counsel must be filed by March 17, 2022. 
•    Position statements are due by March 24, 2022. 
•    Applications/nominations for appointment to the Steering Committee are due by April 7, 2022. 
•    Written objections to applications/nominations for appointment to the Steering Committee are due by April 11, 2022. 
 

Order received from MDL Panel transferring civil action cases to the Eastern District of Louisiana.

The Court entered Pretrial Order No. 4, setting forth the operable Plaintiff Fact Sheet, authorizations, and Defendant Fact Sheet.

The Court entered Pretrial Order No. 3 requesting applications and nominations for the appointment of liaison counsel for the 505(b)(2) Defendants.

The Court appointed liaison counsel and the plaintiffs’ steering committee. 

The Court issued a pretrial order establishing rules and procedures to govern this litigation. The initial pretrial conference will be held on March 31, 2022, at 9:30 a.m. in Judge Jane Triche Milazzo’s courtroom. The Court set the following deadlines:
•    Applications/nominations for the designation of Liaison Counsel must be filed by March 17, 2022. 
•    Position statements are due by March 24, 2022. 
•    Applications/nominations for appointment to the Steering Committee are due by April 7, 2022. 
•    Written objections to applications/nominations for appointment to the Steering Committee are due by April 11, 2022. 
 

The Court entered an Order resetting the July 26, 2023 status conference for September 12, 2023, at 9:00 a.m.

The Court held a status conference.

The Court entered an Order appointing John F. Olinde as Liaison Counsel for the 505(b)(2) Defendants. 

The Court held Science Day. 

The Court set a status conference for March 31, 2023 at 9:00 a.m.

The Court reset Science Day for February 13, 2023 at 9:00 a.m.

The Court ruled on Defendant Sanofi’s Motion to Dismiss for Failure to State a Claim.

The Court ruled on the 505(b)(2) Defendants’ Motion to Dismiss for Failure to State a Claim.

The Court issued an order providing the protocol for Science Day.

The Court issued an order setting Science Day for December 19, 2022 at 9:00 a.m.

The Court held oral argument on Defendants’ Motions to Dismiss for Failure to State a Claim. 

The Court issued an order denying Defendant McKesson’s Motion to Dismiss as moot. 

The Court issued an order continuing Science Day. 

The Court issued an order setting oral argument for October 5, 2022 at 10:30 a.m.

The Court issued an order setting oral argument for October 5, 2022.

The Court held a general status conference and discussed the items set forth in Joint Report No. 24.

The Court held a conference with lead and liaison counsel and discussed the topics on the attached joint agenda. 

The Court held the initial pretrial conference and discussed the topics on the attached joint agenda. 

The Court entered this stipulated order establishing the protocol for streamlined service on Sun Pharmaceuticals, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Sandoz, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Hospira Inc., Hospira Worldwide, LLC f/k/a Hospira Worldwide, Inc., and Pfizer Inc.  

The Court issued this order regarding filing requests for summons and summons returns and waivers.

The Court attached the exemplar Short Form Complaint to be used by counsel when filing their complaints as provided by this Order and Case Management Order No. 2.  

The Court entered this stipulated order establishing the protocol for streamlined service on Sagent Pharmaceuticals, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Actavis LLC f/k/a Actavis Inc. and Actavis Pharma, Inc. 

The Court entered this stipulated order establishing the protocol for streamlined service on Accord Healthcare, Inc.

The Court entered this stipulated order establishing the protocol for streamlined service on sanofi-aventis U.S. LLC. 

The Court set certain deadlines for master and short form complaints, motions to dismiss, and master answers. 

The Court issued a direct filing order. 

Status conference at 9:00 a.m. in Judge Milazzo’s courtroom (C224).

Science Day at 9:00 a.m. in Judge Milazzo’s courtroom (C224). 

Oral argument on Defendants’ Motions to Dismiss at 10:30 a.m. in Judge Milazzo’s courtroom (C224).

Lead and Liaison Counsel conference at 1:00 p.m. in Judge Milazzo’s courtroom (C224).

Pretrial conference at 9:30 a.m. in Judge Milazzo’s courtroom (C224).